The Drug Information Association (DIA), a global professional member association, and Kaplan EduNeering, a leading provider of compliance and knowledge management solutions, announced a new strategic alliance to create online educational offerings for biotechnology, pharmaceutical, academic, and regulatory professionals around the world.
DIA addresses solutions to issues and challenges involved in the discovery, development, and lifecycle management of pharmaceuticals, medical devices, and related products. DIA members will now have access to Kaplan EduNeering’s online compliance solutions used by over one million individuals in more than 50 countries.
“Our constituents represent a diverse global group of pharmaceutical and medical device development professionals all coming together to achieve their common professional aspirations essential to innovation in today’s healthcare industry,” explained Paul Pomerantz, DIA Worldwide Executive Director. “Kaplan EduNeering’s e-learning educational programs provide a strong complement to DIA’s education programs and commitment to professional advancement. The easily accessible learning tools will help our professionals excel in their day-to-day professional roles.”
Under the agreement, DIA and Kaplan EduNeering have created a solution that addresses the discovery, development and life cycle management training objectives of DIA’s constituents. Key topics range from:
- Good Clinical Practices (GCP)
- Selecting and Managing Contract Research Organizations (CROs)
- Drug and Medical Device Safety and Adverse Event Reporting
- Good Manufacturing Practices (GMP)
In the future, the solution will include new content emerging from DIA’s select training courses.
“We are very pleased to be partnering with DIA, a member-driven association committed to providing a neutral forum for knowledge exchange that fosters innovation to improve health and well-being worldwide,” said Lisa Clune, President of Kaplan EduNeering. “As global regulatory and business issues increase in complexity, today’s professionals are required to expand their knowledge to address these challenges. Kaplan EduNeering assures our clients develop the critical training and expertise needed to perform their work. We look forward to working with DIA to build learning programs that not only achieve those goals, but also expand professional skills and opportunities.”
About the Drug Information Association (DIA)
DIA (www.diahome.org) is a neutral, global, professional, member-driven association of nearly 18,000 biotechnology, pharmaceutical, academic, and regulatory professionals. Through our international educational offerings and myriad networking opportunities, DIA provides a global forum for knowledge exchange that fosters the innovation of products, technologies, and services to improve health and well-being worldwide. Headquarters are in Horsham, PA, USA, with offices in Basel, Switzerland, Tokyo, Japan, Mumbai, India, and Beijing, China.
About Kaplan EduNeering
(www.kaplaneduneering.com) develops technology-enabled knowledge solutions for assuring regulatory compliance and improving business performance. Kaplan EduNeering is headquartered in Princeton, N.J., and has offices in Houston, TX, Bloomsburg, PA, and London, UK. Kaplan EduNeering is a subsidiary of Kaplan Inc., a leading global provider of educational services to individuals, schools and businesses. Kaplan Inc. is a subsidiary of The Washington Post Company (NYSE: WPO).